Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies.
Diederik P StaalPaul M HendriksMitch C J van ThorLiza D van de GroepLeon M van den ToornBerend-Jan M MulderPrewesh P ChandoesingRobert M KaulingSanne BoermanAnnemien E van den BoschJohannes J MagerKarin A BoomarsMartijn C PostPublished in: Pulmonary circulation (2024)
Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.